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Objective: To investigate the risk factors of perirenal hematoma (PRH) after ﬂexible ureteroscopic lith-
otripsy (FURSL).
Materials and methods: We retrospectively reviewed the medical records of 45 patients who underwent
FURSL with a holmium:yttriumealuminumegarnet laser. We divided all patients in two groups: the PRH
group and the non-PRH group. The patient demographic and baseline characteristics, surgical outcomes,
and complications were compared and risk factors were identiﬁed and analyzed.
Results: Of the 45 consecutive patients treated with FURSL, four (8.9%) developed PRH. Compared with
patients without PRH, patients with PRH had a lower body mass index (BMI; 20.2 ± 3.2 kg/m2 vs
26.9 ± 5.5 kg/m2, p ¼ 0.015), thinner kidney cortex thickness (0.88 ± 0.41 cm vs 1.39 ± 0.41 cm,
p ¼ 0.024), and a history of chronic kidney disease (CKD; 75% vs 14.6%, odds ratio ¼ 17.5, conﬁdence
interval ¼ 1.55e197.46, p ¼ 0.021). However, patient age, diabetes mellitus, hypertension, liver disease,
coronary artery disease, history of urolithiasis, presence of multiple stones, and stone size and location
were comparable in both groups. Three patients with PRH were successfully managed with conservative
treatment. One patient with PRH underwent an emergency nephrectomy within 1 day but died 2 weeks
later despite vigorous resuscitation.
Conclusion: Among our patients, those with lower BMI, CKD, and a thinner renal cortex had a higher risk
of developing PRH after FURSL. Endourologists should have a heightened awareness for potential PRH
when treating patients who present with low BMI, CKD, and a thin renal cortex.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Many studies of ureteroscopic lithotripsy (URSL) using a hol-
mium:yttriumealuminumegarnet (Ho:YAG) laser have demon-
strated its effectiveness and safety in managing ureteral stones. The
major complication rates associated with using this treatment
method are low, and Bai and associates1 reported only 11 (0.4%)
cases of perirenal hematoma (PRH) in 2848 patients who received
URSL operations. In urological daily practice, PRH is a common
complication of extracorporeal shock wave lithotripsy, renal
trauma, and renal angiographic procedures.2,3 In addition, PRH can
occur spontaneously in patients with malignancy and patients onChu Kong Hospital,
i City 23702, Taiwan.
ng).
ociation. Published by Elsevier Taanticoagulation therapy.4 To our knowledge, previous reports on
PRH after ﬂexible URSL (FURSL) are scarce.
With the advances in technology, FURSL is viewed as an
alternative for managing proximal ureteral stones and renal
stones in selected patients.5 In previous reports, only two case
reports mentioned PRH after FURSL.6,7 However, we observed
several episodes of PRH after FURSL in our institution and sus-
pected that the exact incidence of PRH after FURSL might not be as
low as suggested previously. When performing FURSL, the irri-
gation pressure is usually higher than the pressure in conven-
tional URSL to maintain adequate vision.8 We propose that high
intrarenal pressure and other factors may be associated with
postoperative PRH. However, more attention to this potentially
serious complication is warranted. Therefore, to clarify the rela-
tionship between PRH and FURSL, we conducted a retrospective
study to investigate the risk factors for developing PRH after
FURSL.iwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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After Institutional Review Board approval, we identiﬁed 45
consecutive patients treated with FURSL using the Ho:YAG laser for
proximal ureteral stones and renal stones between January 2011 and
September 2014 at a regional hospital (Identiﬁer ECK-IRB1021006).
Informed consent requirement was waived for this study, and pa-
tient informationwas retrospectively reviewed from a prospectively
collected database that recorded the hospital chart data and com-
plications of all patients treated with FURSL. Patient data included
age, sex, body mass index (BMI), and medical history [e.g., chronic
kidney disease (CKD), hypertension, diabetes mellitus, liver disease,
and coronary artery disease]. In addition, information on stone lat-
erality, location and size, operation time, and preoperative labora-
tory data was collected. For CKD staging, estimated glomerular
ﬁltration rate was calculated using the Chronic Kidney Disease
Epidemiology Collaboration formula for each patient.9 Patients who
met the criteria for Stage 3 (moderately decreased glomerular
ﬁltration rate 30e59 mL/min/1.73 mm2) or greater were deﬁned as
patients with CKD. Hematuria was deﬁned as a red blood cell count
greater than three cells/high-power ﬁeld, pyuria was deﬁned as a
white blood cell count greater than ﬁve cells/high-power ﬁeld, and
signiﬁcant bacteriuria was deﬁned as greater than 105 colony-
forming units.10 Stone size and location were determined by either
noncontrast computed tomography (CT) or a kidneyeuretereblad-
der X-ray. The degrees of hydronephrosis and postoperative PRH
were diagnosed based on ultrasonography results and further
conﬁrmed by CT ﬁndings in suspected patients. PRH was deﬁned as
hematoma resulting from a perirenal hemorrhage. The degree of
hydronephrosis was mainly deﬁned by ultrasound and classiﬁed
into the following four groups: no urinary system dilatation, mild
dilatation of the renal pelvis, and moderate and severe dilatation of
the renal pelvis and calices. The stone and hematoma sizes were
measured at the maximum diameter on the radiograph. The mea-
surement of renal cortex thickness was taken over a medullary
pyramid, perpendicular to the capsule as the shortest distance from
the base of the medullary pyramid to the renal capsule.1
All FURSL procedures were performed under light intravenous
or general anesthesia in the lithotomy position. The whole opera-
tion was monitored using c-arm ﬂuoroscopy. First, ureteroscopy
was established with a semirigid 6.5-F ureteroscope (Richard Wolf
GmbH, Knittlingen, Germany). A 0.035-in. hydrophilic ﬂoppy
Nitinol core guidewire (HiWire; Cook Medical, Bloomington, IN,
USA) was inserted into the renal collecting system. Next, a 12-F
ureteral access sheath (Cook Medical, Bloomington) was inserted
into the proximal ureter along the guidewire under ﬂuoroscopic
guidance. The ﬂexible ureteroscope (X2; Karl Storz, Tuttlingen,
Germany) was then advanced via the ureteral access sheath. Any
stones were identiﬁed and fragmented using the Ho:YAG laser with
a laser ﬁber diameter of 200 mm (Sphinx 30 Litho; LISA LaserTable 1
Demographic data and clinical outcomes of the four patients with perirenal hematoma a
Case no. Sex Age (y) Stone site, size Underlying disease
1 F 72 Left staghorn stone, 3.5 cm HTN, CKD Stage V
2 F 51 Right staghorn stone, 5 cm DM, HTN, CKD Stage IV
3 F 76 Left renal stone, 2 cm DM, HTN, CKD Stage V
4 F 50 Left UPJ stone, 0.9 cm No
CKD ¼ chronic kidney disease; DM ¼ diabetes mellitus; HTN ¼ hypertension; ICU ¼ inte
a Aspirin: The patient used aspirin but stopped using it 1 week before the surgery.Products, Katlenburg-Lindau, Germany). The laser energywas set at
1.0e1.5 J and a pulse rate of 5e10 Hz was used based on the sur-
geon's judgment. Stone fragmentation was considered complete
when a particle size of approximately 2e3 mm was visible on
ﬂuoroscopy. Stone fragments were not extracted to avoid ureteral
injury and save time. During the operation, we performed FURSL
with a perfusion pressure of up to 200 mmHg. After the procedure,
an indwelling 6-F double-J ureteral stent (Bioteq, Yilan, Taiwan)
was placed in the ureter of each patient. The stent remained in situ
for 2e4 weeks postoperatively until the patients were stone-free
on follow-up radiography. Image protocols included kidney-
eureterebladder plain X-ray and renal ultrasonography to conﬁrm
PRH formation and to verify stone passage. CT scan would be ar-
ranged for patients who were suspected to have PRH or other
critical conditions (e.g., unstable hemodynamics, severe ﬂank pain,
and urosepsis).
2.1. Statistical analysis
Means with standard deviations were calculated for parametric,
continuous variables. Categorical data were expressed as numbers
and percentages. Median values of continuous variables were
compared using the ManneWhitney U test, whereas categorical
variables were compared using the Fisher exact test. A value of
p < 0.05 was considered statistically signiﬁcant.
3. Results
Among the 45 patients who underwent FURSL with the Ho:YAG
laser, postoperative PRH occurred in four (8.9%) patients. Table 1
shows that these four patients were female with a mean age of
62.3 ± 13.7 years (range 50e76 years). The median stone size was
2.85 cm (range 0.9e5 cm). Three patients had renal stones
including two staghorn stones and one lower calyx stone, whereas
the remaining one had a stone in the ureteropelvic junction. Three
patients with PRH had CKD and a thin renal cortex. One patient had
been using aspirin but stopped using it 1 week before FURSL. This
76-year-old female patient (BMI 18.3 kg/m2) developed a progres-
sive huge left PRH (Figure 1) and hemodynamic instability several
hours after the operation. Her serum hemoglobin level decreased
from 10.3 g/dL to 6.1 g/dL. Emergency angiography showed a small
left renal artery without active bleeding point. However, her vital
signs remained unstable even under vigorous resuscitation and
inotropic agents. She underwent an emergency open left ne-
phrectomy. The operative ﬁnding showed thin renal parenchyma
and a renal laceration (approximately 3 cm) in the lower pole.
However, multiple organ failure and urosepsis occurred despite
vigorous resuscitation. She expired 2 weeks after the nephrectomy.
Table 2 compares the demographic data, underlying medical
diseases, and preoperative and postoperative characteristicsfter ﬂexible ureteroscopic lithotripsy.
Anticoagulant
use
Cortex
thickness
(cm)
OP time
(min)
Management/outcome
No 0.92 95 Conservative treatment/spontaneous
resolution
No 0.80 89 ICU and blood transfusion/spontaneous
resolution
Yes, aspirina 0.40 81 Emergency left nephrectomy/expired
No 1.40 78 Conservative treatment/spontaneous
resolution
nsive care unit; OP ¼ operation time; UPJ ¼ ureteropelvic junction.
Figure 1. Abdominal computed tomography scan shows perirenal hematoma in the
left kidney (arrowhead) and a huge retroperitoneal hematoma (arrow) in a female
patient 12 hours after undergoing ﬂexible ureteroscopic lithotripsy.
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postoperative PRH had signiﬁcantly lower BMI (20.0 ± 3.2 kg/m2 vs
26.9 ± 5.5 kg/m2, p ¼ 0.015) and a thinner renal cortex
(0.88 ± 0.41 cm vs 1.39 ± 0.41 cm, p ¼ 0.024) compared with those
without PRH. In addition, a signiﬁcantly higher percentage of pa-
tients with PRH had CKD (75% vs 14.6%, p ¼ 0.021) compared with
patients without PRH. Nine patients with CKD had signiﬁcant
thinner cortex thickness than 36 patients without CKD
(1.06 ± 0.41 cm vs 1.38 ± 0.40 cm, p ¼ 0.037). However, age, sex,
history of hypertension, diabetes, coronary heart disease, liver
disease, operative time, use of anticoagulant agents, stone size and
location, pyuria, hematuria, and bacteriuria were not statistically
associated with developing PRH.
BMI less than 18.5 kg/m2 is deﬁned as “underweight” by the
World Health Organization.11 We used this BMI (18.5 kg/m2) and
renal cortex thickness of 1 cm as cutoff points to evaluate the risk.
Table 3 shows higher odds ratios (ORs) for CKD [OR ¼ 17.5, conﬁ-
dence interval (CI) ¼ 1.55e197.46, p ¼ 0.021], being underweight
(OR ¼ 19.5, CI ¼ 1.73e219.48, p ¼ 0.034), and having a thin renal
cortex (OR ¼ 12.5, CI ¼ 1.13e135.23, p ¼ 0.04) when comparing the
PRH groupwith the non-PRH group. In addition, two patients in the
non-PRH group experienced postoperative fever, which subsided
after antibiotic treatment during hospitalization. One female pa-
tient in the non-PRH group developed a right, upper ureteral
stricture after FURSL. No other major complications occurred in
either group.4. Discussion
In this pioneering study, the key ﬁnding was that the incidence
of PRH after FURSL was not as low as previously reported.6,7 In
particular, we demonstrated that patients with low BMI, thin renal
cortex, and a history of CKD had a higher risk of developing PRH
after undergoing FURSL. PRH is frequently reported after extra-
corporeal shock wave lithotripsy and percutaneous neph-
rolithotomy, but not after FURLS.2,4
Identifying the risk factors for PRH is important for endour-
ologists performing FURSL for ureteral or renal calculi. PRH most
often occurred in patients with low BMI. Patients with low BMI
have less body fat, and therefore, less perirenal fat than the
higher BMI group. When the kidney is injured, the perirenal fat
provides an adequate cushion for the kidney to avoid cortex
overstretching from the increased renal pelvis irrigation pres-
sure. Kidneys with less perirenal fat were vulnerable to PRH
formation. Two of the four patients in the PRH group were un-
derweight based on their BMIs. We propose that being under-
weight could imply malnutrition, and therefore, the structure of
kidney may be weaker than that of patients with normal BMIs.
Our ﬁnding differs from that of Chiu et al12 who found that obese
patients with a BMI greater than 24 mg/m2 often had PRH after
URSL. They reported that obesity may cause increased difﬁculty
in guidewire placement and ureteroscope advancement, thus
increasing the chance of injury to the system. In our experience
with FURSL, we inserted the ureteral access sheath along with
guidewire before FURSL. Our protocol called for abandoning the
procedure in the case of difﬁculty during ﬂexible ureteroscope
advancement to avoid unpredictable ureteral or renal injury.
Different surgical considerations could cause different compli-
cation rates. Thus, further in vivo or in vitro studies should be
conducted to clarify the differences.
CKD could have played an important role in the development
of PRH in our study. In the patients with CKD, the renal cortex
was relatively thin.13 The kidney structure of patients with CKD
was weaker than that of the patients with healthy kidneys.
When facing high irrigating pressure, the weaker kidney struc-
ture was easily damaged. However, this hypothesis is not sup-
ported by the study of Yuruk et al14 who showed that FURSL was
safe and effective in patients with CKD, and no PRH was noted
among 62 patients. This discrepancy could be explained by the
use of two different sizes of ﬂexible ureteroscopes in their study,
either a 7.5-F or an 8.5-F ﬂexible ureteroscope. We used only the
7.5-F ﬂexible ureteroscope. We assumed that the bigger lumen
of ﬁberscope required less irrigating pressure to maintain
adequate vision. However, because no irrigation pressure was
recorded by Yuruk et al,14 how to achieve a balance between
adequate vision and lower intrarenal pressure still needs to be
investigated.
We routinely used the ureteral access sheath, which provided
protection against elevated renal pressures during FURSL.15 How-
ever, for better vision, we used a higher irrigating pressure
(200 mmHg) during FURSL than the pressure applied during use of
a semirigid ureteroscope.14 Transiently high renal pelvis pressure
changes may cause minor trauma in healthy kidneys. Unfortu-
nately, in patients with CKD, the sudden change of renal intrapelvic
pressure can induce the sudden expansion and rupture of the renal
parenchyma and capsular vessels. When a subcapsular renal he-
matoma occurs, it can progress into a PRH if the perirenal fat is thin.
Three of the four patients in the PRH group underwent FURSL for
renal stones. The kidney would encounter higher intrarenal pres-
sure during FURSL for a renal stone compared with FURSL for a
proximal ureteral stone with the use of ureteral access sheath.15
Therefore, urologists should keep adequate pressure and be
Table 2
Comparison of preoperative and postoperative characteristics of the non-PRH and PRH groups.
Characteristic Non-PRH (n ¼ 41) PRH (n ¼ 4) p
Age, mean ± SD, y 57.3 ± 14.7 62.3 ± 13.7 0.527
Sex 20 males, 21 females 0 males, 4 females 0.117
Male 20 0
Female 21 4
BMI, mean ± SD, kg/m2 26.9 ± 5.5 20.0 ± 3.2 0.015
Hypertension, n (%) 19 (46.3) 1 (25) 0.345
Diabetes mellitus, n (%) 15 (36.6) 2 (50) 0.626
Chronic kidney disease, n (%) 6 (14.6) 3 (75) 0.021
Liver disease, n (%) 6 (14.6) 0 (0) >0.99
Coronary artery disease, n (%) 8 (19.5) 1 (25) >0.99
Anticoagulant agents, n (%) 10 (24.3) 1 (25) >0.99
History of urolithiasis, n (%) 28 (63) 2 (50) 0.591
Pyuria, n (%) 24 (58.5) 3 (65) 0.640
Hematuria, n (%) 19 (46.3) 2 (50) >0.99
Bacteriuria, n (%) 11 (26.8) 4 (100) 0.082
Urosepsis after operation 3 (7.3) 4 (100) <0.001
Prothrombin time, INR, median (range) 1.003 (0.91e1.32) 1.009 (0.94e1.08) 0.894
Prothrombin time INR, mean ± SD 1.00 ± 0.08 1.00 ± 0.05 0.894
Operation time, mean ± SD, min 85.1 ± 7.1 118.9 ± 60.9 0.319
Renal cortex thickness, mean ± SD, cm 1.39 ± 0.41 0.88 ± 0.41 0.024
Stone size, median, mean ± SD, cm 2.00 ± 1.21 2.85 ± 1.78 0.384
Stone laterality, n 0.611
Left 21 3
Right 20 1
Stone location, n 0.740
UPJ or upper ureter 18 1
Upper calyx 0 0
Middle calyx 2 0
Lower calyx 10 1
Staghorn stone 11 2
Hydronephrosis, n 0.344
No 20 3
Mild 12 1
Moderate 9 0
Severe 0 0
ClavieneDindo grade, n
Grade I: postoperative fever 2 0
Grade II: requires blood transfusion 0 3
Grade III: ureteral stricture 1 0
Grade IV: required emergency nephrectomy 0 1
BMI ¼ body mass index; INR ¼ international normalized ratio; PRH ¼ perirenal hematoma; SD ¼ standard deviation; UPJ ¼ ureteropelvic junction.
Table 3
Risk factors for perirenal hematoma after ﬂexible ureteroscopic lithotripsy.
Risk factors PRH vs non-PRH group
CKD 75% vs 16%, OR ¼ 17.5, CI: 1.55e197.46 (p ¼ 0.021)
BMI < 18.5 50% vs 4.8% OR ¼ 19.5, CI: 1.73e219.48 (p ¼ 0.034)
Renal cortex
thickness < 1 cm
75% vs 19.5% OR ¼ 12.5, CI: 1.13e135.23 (p ¼ 0.04)
BMI ¼ body mass index < 18.5 was deﬁned as underweight; CI ¼ conﬁdence
interval; CKD ¼ chronic kidney disease; OR ¼ odds ratio; PRH ¼ perirenal
hematoma.
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higher in the renal pelvis.
Our study also showed that presurgical bacteriuria was 100%
in the PRH group and only 26.8% in the non-PRH group
(p ¼ 0.082). Preoperative bacteriuria implies a subclinical urinary
tract infection. Urinary tract infections can cause inﬁltration of
neutrophils into the renal tissue accompanied by the destruction
of the renal parenchyma. This makes the renal parenchyma
prone to bleeding, which facilitates the formation of the PRH.7 If
a subclinical urinary tract infection progressed into a severe
systemic infection after FURSL, it could also disturb the coagu-
lation system and speed hematoma development. In addition,
during FURSL, the operator may accidentally thrust the laser ﬁber
or emit laser energy into the kidney. These actions could inducekidney lacerations, which carry bacteria into the systemic cir-
culation, resulting in urosepsis or PRH. Another noticeable
ﬁnding in our study was that all of the patients who developed
PRH were female. Many epidemiological studies have shown that
urinary tract infections are more common in female patients.16 In
another study, female sex was also found to be a risk factor for
PRH after conventional URSL.17 Taking together, we advocate that
providing adequate infection control in women with urinary tract
infections is essential before FURSL.
One important motivation to report our study was that one pa-
tient died 2 weeks after undergoing FURSL. This female patient un-
derwent an emergency nephrectomy for a massive, progressive
hematoma (Figure 1) resulting in hemodynamic instability. The renal
cortex was thin (<1 cm), and the kidney showed a 3-cm laceration
without rupture into the renal pelvis. Multiple organ failure and
urosepsis ensued despite vigorous resuscitation efforts. Except this
patient, we applied conservative treatment to the other three pa-
tients with PRH. All hematomas resolved spontaneously in the
following months. One patient in the non-PRH group experienced
repeated ureteral strictures after FURSL. We performed internal
dilationwithmultiple ureteral stents to resolve thehydronephrosis.18
No other signiﬁcant complications were noted in either group.
The ideal timing for surgical intervention remains unclear. A
PRH related to a previous FURSL procedure may be treated similar
to a blunt kidney injury. If the patient experiences loin pain or ﬂank
M.-H. Kao, C.-C. Wang / Urological Science 27 (2016) 166e170170pain after undergoing FURSL, the surgeon should examine serum
hemoglobin and perform abdominal sonography or CT to ascertain
whether or not the patient has a PRH. Percutaneous hematoma
drainage was used for patients with huge hematomas with a sig-
niﬁcant mass effect. Percutaneous drainage may decrease hema-
toma progression in patients with stable vital signs, but unbearable
pain or renal compression could result.19 If serum hemoglobin
decreases persistently, angiographic intervention should be used to
treat the kidney bleeding site. Open surgical intervention should be
performed as soon as possible if conservative treatment or angio-
graphic intervention fails to resolve the bleeding.
The incidence of PRH after FURSL might not be low as previously
reported. In clinical practice, we believe that the incidence of PRH
after semirigidURSL is quite low.However, the incidence of PRHafter
FURSL was not low as we thought and not as low as previously re-
ported.Wehypothesize that the irrigationpressure, cortex thickness,
BMI, and CKD play critical roles in PRH formation. The irrigation
pressure of URSL used in our hospital was approximately
100e150 mmHg, which is lower than that typically used in FURSL
(200mmHg). Our results suggest that a higher perfusionpressure for
hydraulic irrigation might lead to the development of a greater
number of PRHs than a lower perfusion pressure. Therefore, to pre-
vent PRH after FURSL in the future, we recommend three signiﬁcant
changes to the FURSL procedure. First, any urinary tract infection
shouldbe eradicated before performing FURSL. Second, the irrigation
pressure during the FURSL in patients with low BMI and a history of
CKD should be strictly reduced to avoid laceration or rupture of the
renal cortex. Third, when performing FURSL in females, in particular,
surgeons should take extra care to insert FURSL instruments into the
ureter gently to avoid any trauma during the operation.
Delayed onset of PRH is possible after FURSL. Bai et al1 reported
that 11 patients with PRH presented with severe ipsilateral ﬂank
pain or a palpable mass within a day of surgery but no delayed
onset of PRHwas noted in their study. In a study by Chiu et al,12 two
patients with PRH presented with loin pain and signiﬁcant hemo-
globin drop within 2 days of URSL and one patient presented on
Day 20. Tao et al20 reported that two patients with PRH in their
study had loin pain (on the operated side) and fever within 1 day of
URSL and one patient presented on Day 10.20 According to these
reports, it might be necessary to follow-up our patients using renal
sonography regularly. However, all these patients with delayed
onset of PRH were symptomatic and further examinations were
performed to identify PRH. In our series, because the patients in the
non-PRH group were asymptomatic during follow-up, we assumed
that these patients might have no PRH.
5. Limitations
This study is obviously limited by its retrospective nature and
the relatively small number of PRH cases encountered. This limits
the applicability of the statistical analysis between the patient
groups. However, there are few studies to date directly reporting
the risk factors and outcomes of patients with PRH after FURSL. In
addition, because the health insurance system in Taiwan could not
reimburse the cost of FURSL, which is so popular in Western
countries, the case number was small. However, to our knowledge,
there is no Taiwanese report about FURSL published in PubMed.
Our preliminary ﬁndings and experience might provide some les-
sons for Taiwanese urologists who are interested in this technique,
although this was a retrospective study.
6. Conclusion
Patients with a low BMI, history of CKD, and a thin renal cortex
appear to have a higher risk of developing PRH after FURSL.Endourologists should have heightened awareness of a patient
developing a PRH when the patient presents with this potentially
dangerous combination of factors before an FURSL operation.
Alternative treatment options should be considered before FURSL if
possible. Future prospectively conducted studies should be carried
out to determine the actual incidence of PRH after FURSL.Conﬂicts of interest
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